COINTURK FINANCECOINTURK FINANCECOINTURK FINANCE
  • Investing
  • Technology News
  • Business
  • Fintech
  • Startup
  • About Us
  • Contact
Search
Health
  • About Us
  • Contact
Entertainment
  • Investing
  • Business
  • Fintech
  • Startup
© 2024 BLOCKCHAIN IT. >> COINTURK FINANCE
Powered by LK SOFTWARE
Reading: 4D Medicine Raises £3.4m for 3D Printed Medical Devices
Share
Font ResizerAa
COINTURK FINANCECOINTURK FINANCE
Font ResizerAa
Search
  • Investing
  • Technology News
  • Business
  • Fintech
  • Startup
  • About Us
  • Contact
Follow US
© 2025 BLOCKCHAIN Information Technologies. >> COINTURK FINANCE
Powered by LK SOFTWARE
Track all markets on TradingView
COINTURK FINANCE > Startup > 4D Medicine Raises £3.4m for 3D Printed Medical Devices
Startup

4D Medicine Raises £3.4m for 3D Printed Medical Devices

Overview

  • 4D Medicine secured £3.4m in Series A funding.

  • The funds will support pre-clinical testing and FDA approval efforts.

  • 4Degra biomaterial offers advantages in developing novel medical implants.

COINTURK FINANCE
COINTURK FINANCE 10 months ago
SHARE

4D Medicine, a UK-based biotech firm specializing in biomaterials for 3D printed implants and surgical devices, has successfully secured £3.4m in a Series A funding round. This investment will facilitate the completion of pre-clinical testing for their first product range, ultimately aiming for FDA clearance to enter the US market. The company, a spin-out from the Universities of Birmingham and Warwick, is leveraging its novel resorbable biomaterial, 4Degra, in developing advanced medical implants.

Contents
Innovative Biomaterial TechnologyExpanding Potential Applications

Information from earlier reports shows that 4D Medicine has consistently drawn interest from leading industry players and investors, evidenced by their previous funding successes. The company has continued to improve its technology and cement its position in the burgeoning bioresorbable medical device market. Prior investments have been crucial in establishing the firm’s foundational technology and early-stage development, which has now culminated in this significant Series A round.

The new funding round was led by Oshen Holdings and supported by DSW Ventures, SFC Capital, Boundary Capital, and several private investors, including prominent scientists and surgeons. The accumulated £3.4m will support 4D Medicine in completing the pre-clinical testing of its initial product line and pursuing FDA approval for entry into the lucrative US market.

Innovative Biomaterial Technology

4D Medicine has developed a resorbable biomaterial named 4Degra, which shows promise in creating implants such as orthopaedic devices and soft tissue scaffolds. The material degrades gradually without releasing harmful acidic by-products, a significant advantage over current resorbable biomaterials that can cause pain and inflammation. This property of 4Degra facilitates better patient recovery post-surgery or injury.

Expanding Potential Applications

The ability to 3D print 4Degra into complex shapes allows for diverse applications in medical devices, ranging from flexible films and membranes to more rigid products like plates and bone scaffolds. This versatility opens up new possibilities for the development of customized implants tailored to individual patient needs. Since its founding in 2020, 4D Medicine, now based in Nottingham, has raised a total of £5m, with plans to seek Series B investment early next year.

CEO Philip Smith expressed his gratitude towards the investors, emphasizing the importance of their support in the company’s progress, especially under challenging market conditions. The funds will enable the company to move forward with their pre-clinical testing and market entry preparations. Similarly, Didier Cowling from Oshen Holdings highlighted the potential impact of 4D Medicine’s innovations in the bioresorbable medical device sector.

DSW Ventures’ Doug Quinn noted the significant interest from large industry players, including potential acquirers, that 4D Medicine has garnered. This highlights the company’s innovative approach and its potential to secure regulatory clearance in the US, targeting a market worth £5bn. Jason Druker from SFC Capital lauded the progress made by 4D Medicine since their initial investment, showing excitement for the future impact of their medical device products.

4D Medicine’s advancements in biomaterial technology present a promising future for the medical field, especially in creating safer and more effective resorbable implants. Their recent funding success demonstrates strong investor confidence and sets the stage for significant growth and innovation in the coming years. As the company moves towards regulatory clearance and market entry, its technology could revolutionize how medical implants are developed and utilized.

You can follow our news on Telegram and Twitter (X)
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

You Might Also Like

Startups Across Europe Secure Multi-Million Funding to Accelerate Growth Initiatives

Walmart Implements AI Strategies to Transform Retail Experience

AWS Expands Global Data Centers to Power AI Growth

Grammarly Secures $1 Billion to Expand A.I. Capabilities and Market Presence

Outmin Secures €4M to Enhance Its AI-Driven Financial Platform

Share This Article
Facebook Twitter Copy Link Print
Previous Article Minnesota Debates Carbon-Free Energy Sources
Next Article OpenAI Challenges Google’s Dominance
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Credit Card Management Challenges Rise with Increasing Numbers
COINTURK FINANCE COINTURK FINANCE 14 hours ago
SpaceX Propels Forward with Busy June Launch Schedule
COINTURK FINANCE COINTURK FINANCE 14 hours ago
Retirees Select Top Dividend Stocks for Stability and Income
COINTURK FINANCE COINTURK FINANCE 16 hours ago
Tesla Shares Surge as Musk Returns to Focus on Company
COINTURK FINANCE COINTURK FINANCE 18 hours ago
Penny Production Ends as U.S. Treasury Seeks Efficiency
COINTURK FINANCE COINTURK FINANCE 1 day ago
//

COINTURK was launched in March 2014 by a group of tech enthusiasts focused on the internet and new technologies.

CATEGORIES

  • Investing
  • Business
  • Fintech
  • Startup

OUR PARTNERS

  • COINTURK NEWS
  • BH NEWS
  • NEWSLINKER

OUR COMPANY

  • About Us
  • Contact
COINTURK FINANCECOINTURK FINANCE
Follow US
© 2025 BLOCKCHAIN Information Technologies. >> COINTURK FINANCE
Powered by LK SOFTWARE
Welcome Back!

Sign in to your account

Lost your password?